PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.72
ESG score 90-95% of SGMO's 65.31. Bill Ackman would demand clear ESG improvement catalysts.
58.63
Environmental score 90-95% of SGMO's 62.41. Bill Ackman would demand clear environmental improvement catalysts.
59.61
Social score 80-90% of SGMO's 71.77. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.92
Similar governance score to SGMO's 61.74. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.